Utepreva Introduces FDA 510(k)-Cleared Endometrial Sampler Designed to Support Early Detection of Endometrial Cancer

B The innovative device supports early diagnosis when survival outcomes are most favorable. NEW YORK, April 22, 2026 /PRNewswire/ — Utepreva LLC today announced the launch…
posteditor
posteditor
Articles: 17424

Other News